BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16877877)

  • 1. Effects of VLDL and remnant particles on platelets.
    Olufadi R; Byrne CD
    Pathophysiol Haemost Thromb; 2006; 35(3-4):281-91. PubMed ID: 16877877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J; Hudecek J; Kubisz P
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
    Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
    Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelets, coagulation, and fibrinolysis in atherosclerosis formation].
    Ishii H; Yoshida M
    Nihon Rinsho; 2011 Jan; 69(1):50-4. PubMed ID: 21226260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
    J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN; Mosnier LO
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolysis in diabetes.
    Banga JD
    Semin Vasc Med; 2002 Feb; 2(1):75-86. PubMed ID: 16222598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins and the haemostatic system in atherothrombotic disorders.
    Miller GJ
    Baillieres Clin Haematol; 1994 Sep; 7(3):713-32. PubMed ID: 7841607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging analyses of coagulation-dependent initiation of fibrinolysis on activated platelets and its modification by thrombin-activatable fibrinolysis inhibitor.
    Brzoska T; Suzuki Y; Sano H; Suzuki S; Tomczyk M; Tanaka H; Urano T
    Thromb Haemost; 2017 Apr; 117(4):682-690. PubMed ID: 28150854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemostatic system.
    Stassen JM; Arnout J; Deckmyn H
    Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation activation and fibrinolysis during a downhill marathon run.
    Sumann G; Fries D; Griesmacher A; Falkensammer G; Klingler A; Koller A; Streif W; Greie S; Schobersberger B; Schobersberger W
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):435-40. PubMed ID: 17581317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and coagulation.
    Levi M; van der Poll T
    Crit Care Med; 2010 Feb; 38(2 Suppl):S26-34. PubMed ID: 20083910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
    Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
    Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    GuimarĂ£es AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of platelets and leukocytes in coagulation and fibrinolysis.
    Cucuianu M; Trif I
    Rev Roum Physiol (1990); 1992; 29(1-2):33-8. PubMed ID: 1472550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.